Skip to content

A study of Traditional Chinese medicine "Bian Zheng Lun Zhi" in the treatment of patients with Hand, Foot and Mouth Disease complicated with central nerve system infection

A study of Traditional Chinese medicine "Bian Zheng Lun Zhi" in the treatment of patients with Hand, Foot and Mouth Disease complicated with central nerve system infection

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000947
Enrollment
Unknown
Registered
2010-07-27
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand, Foot and Mouth Disease

Interventions

B:Conventional medicine + Tan Re Qing injection
C:Conventional medicine + Tan Re Qing injection + or

Sponsors

Dong Zhi Men Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. To be accoding to the diagnostic standard of Ministry of Health "Hand, Foot and Mouth Disease diagnosis and treatment guideline, 2010"; 2. To be according to the diagnostic standard of central system infection; 3. To be appeared the central system infection presentations within 48 hours; 4. aged 1 to 6 years old; 5. To be signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe case with any one of following problems: (1) frequently twitch, coma, hernia; (2) difficult breathing, cyanotic, bloody sputum bubble, Pulmonary rales; (3) Cycle dysfunction includes shock; 2. Complicated with epilepsy, tumur, congenital heart disease, kidney disease adn genetic metabolic diseases; 3. Febrile convulsions; 4. Using or long term use hormone for basic diseases; 5. Patient is attending other clinical study of Hand, Foot, Mouth Disease; 6. other patients who to be considered not suit for inclusion.

Design outcomes

Primary

MeasureTime frame
Mortality;Time of fever clearance;Rate of worsing case;

Secondary

MeasureTime frame
Stable time of disease;Adverse event;Consuming of hormone or dehydrating agents;

Countries

China

Contacts

Public ContactYongli Zhang
bjdtyyxx@sina.com+86 010 84322009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026